Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Commercial Services » Miscellaneous Commercial Services
|CRL||Charles River Laboratories International, Inc.||-3.33%||223.55||4.4%||$151.82m|
|FLT||FLEETCOR Technologies, Inc.||-2.63%||232.48||3.8%||$138.65m|
|CDK||CDK Global, Inc.||-0.07%||54.30||2.4%||$131.54m|
|BAH||Booz Allen Hamilton Holding Corp.||4.73%||84.92||2.1%||$92.55m|
|PAGS||PagSeguro Digital Ltd.||-5.98%||13.36||0.0%||$63.36m|
|MRVI||Maravai Lifesciences Holdings, Inc.||-4.43%||34.11||0.0%||$59.88m|
|BFAM||Bright Horizons Family Solutions, Inc.||-2.00%||86.18||1.4%||$59.22m|
|MEDP||Medpace Holdings, Inc.||-0.30%||133.32||1.0%||$55.20m|
|SYNH||Syneos Health, Inc.||-1.27%||70.56||0.0%||$52.57m|
Celularity, Inc. a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other. The Cell Therapy segment consists of the therapies the company is researching and developing. The BioBanking segment focuses on stem cells from umbilical cords and placentas and provides storage of such cells on behalf of individuals for future use. The Degenerative Disease segment offers products used in surgical and wound care markets. The company was founded by Robert J. Hariri in 2016 and is headquartered in Florham Park, NJ.